Feasibility and Safety of Long-term Intrathecal Pseudodelivery of Immunotherapy for Selective Clearance of Csf Amyloid-β in a Mouse Model of Alzheimer’s Disease
Year: 2023
Type: article
Abstract: The cerebrospinal (CSF) sink therapeutic strategy combined with intrathecal pseudo-delivery of drugs are promising approaches for the treatment of neurodegenerative diseases involving the accumulation of toxic and soluble molecules. Indeed, we have recently demonstrated the feasibility of short-term implantation of a fully implantable intrathecal device combined with monoclonal antibodies for selectively clearing amyloid-β (Aβ) from CSF in a mouse model of Alzheimer’s Disease. In the present work, we go a step further by refining both the design and procedures for surgical implantation, as well as the long-term safety and efficacy of the aforementioned implantable device.
Source: IBRO Neuroscience Reports
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W4388364007
